Visionary Wealth Advisors

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1802984 O'FALLON, IL

Position in HALO

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$335,752

New position

Shares Held

5,195

first reported quarter

Ownership

0.004%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Visionary Wealth Advisors holds $1,693,202 across 5 Biotechnology names. HALO ranks #3 (19.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	22,779	$741,228
2	IBRX	ImmunityBio, Inc.	58,760	$450,689
3	HALO	Halozyme Therapeutics, Inc. This page	5,195	$335,752
4	MESO	Mesoblast Ltd	10,325	$158,798
5	CUE	Cue Biopharma, Inc.	29,285	$6,735

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$335,752	5,195	—	Shares	Sole	2026-05-13
No filing history on record for this holder in this stock.